Sahm ScreenerSaudi Stock Screenerفلتر الأسهم السعودية
Home / Nahdi Medical Co. / 2025 Annual Results

Nahdi Medical Co. 2025 Annual Results

Revenue
SAR 10.21B
Net Profit
SAR 831M
EPS
SAR 6.39
Operating Cash Flow
SAR 1.13B

Nahdi Medical Co. (4164) reported full year 2025 revenue of SAR 10.21B, up 8.1% from SAR 9.45B in 2024. Net profit came in at SAR 831M, up 1.2% year on year. Earnings per share were SAR 6.39. The company generated SAR 1.13B in operating cash flow. All figures sourced from CMA-mandated XBRL filings on the Saudi Exchange, processed by Sahm Screener.

Earnings Quality

Of every SAR 1.00 in reported net profit, SAR 1.36 arrived as operating cash flow — indicating Exceptional quality earnings with a cash conversion ratio of 1.36.

Key Financial Metrics

Metric20252024
RevenueSAR 10.21BSAR 9.45B
Net ProfitSAR 831MSAR 821M
Net Margin8.1%8.7%
ROE30.3%31.7%
EPSSAR 6.39SAR 6.31
Total AssetsSAR 6.69BSAR 6.17B
Total EquitySAR 2.74BSAR 2.59B
Total LiabilitiesSAR 3.95BSAR 3.59B
Operating Cash FlowSAR 1.13BSAR 1.49B

Year on Year Comparison

Revenue increased by 8.1% compared to 2024. Net profit increased by 1.2%. Both revenue and profit grew — indicating expanding business.

Financial data sourced from CMA-mandated XBRL filings published on the Saudi Exchange (Tadawul). Data processed and structured by Sahm Screener (sahmscreener.com). Updated nightly. Last updated: 2026-03-24.